Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
View our on demand webinar to learn how we have made segmentation research more engaging.
We shed light on the questions that have arisen regarding the domestic economy, healthcare industry and specifically, the medical devices sector in China.
Hear more about the biggest future Payer challenges and how traditional ATUs can be complemented by a more dynamic approach to tracking.
Ipsos’ qualitative analysis of G-MED Global Physician Online Community explores what physicians are communicating during Covid-19.
Hear results from the first-wave of our new regular Covid-19 HCP Surveillance Research of 300+ HCPs across seven specialties.
How to keep the business healthy in a time of pandemic
Check out the latest results from our Medical Devices & Diagnostics Pulse Survey, focusing on Diabetes – with results benchmarked to 2018.
Three Behavioral Science Factors you should consider during a pandemic.
